1. Home
  2. VSTS vs ANIP Comparison

VSTS vs ANIP Comparison

Compare VSTS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$14.56

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.45

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
ANIP
Founded
1936
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2023
1999

Fundamental Metrics

Financial Performance
Metric
VSTS
ANIP
Price
$14.56
$79.45
Analyst Decision
Sell
Strong Buy
Analyst Count
4
5
Target Price
$5.88
$110.00
AVG Volume (30 Days)
1.2M
238.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
$2,734,839,000.00
$206,547,000.00
Revenue This Year
N/A
$21.01
Revenue Next Year
$1.67
$17.59
P/E Ratio
N/A
$62.88
Revenue Growth
N/A
2.47
52 Week Low
$3.98
$63.67
52 Week High
$16.90
$99.50

Technical Indicators

Market Signals
Indicator
VSTS
ANIP
Relative Strength Index (RSI) 48.20 44.35
Support Level $13.40 $76.87
Resistance Level $15.06 $83.66
Average True Range (ATR) 0.61 2.22
MACD -0.22 -0.04
Stochastic Oscillator 11.72 34.61

Price Performance

Historical Comparison
VSTS
ANIP

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: